US FDA Reforms In 2022: One Bill – Or Four?

The draft bipartisan user fee reauthorization bill includes more than 40 ride-along provisions to make changes at the US FDA. But there are at least three other bills moving in Congress that also make FDA reforms.

Four US Capitols
• Source: Nielsen Hobbs; the Pink Sheet | Shutterstock image

The release of the bipartisan House Energy & Commerce bill to reauthorize the US Food & Drug Administration’s user fee funding programs is a significant legislative milestone.

As is the by now well-established pattern, the every-five-year reauthorization process is an opportunity for Congress to weigh in with...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Pink Sheet for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from User Fees

More from Pathways & Standards